The trajectory of companies tied to the drug's history presents a challenging investment picture . While the initial surge generated substantial profits , generic competition have significantly eroded https://thekiwisocial.com/story7227971/the-copyright-and-the-pharmaceutical-sector-a-risky-opportunity